AVITA Medical is a therapeutic acute wound care company that develops and commercializes innovative solutions for treating burns, traumatic injuries, and surgical wounds. The company's core portfolio includes RECELL, an autologous cell harvesting technology that enables clinicians to create a suspension of a patient's own skin cells for wound treatment using a small donor skin sample; PermeaDerm, a biosynthetic wound matrix; and Cohealyx, a collagen-based dermal matrix for wound bed preparation. AVITA's primary customers are specialized burn centers, trauma centers, and surgical centers across the United States and international markets, with revenue generated through device sales reimbursed via hospital diagnosis-related groups and physician procedure codes.